Kelly Michael Aaron Insider Trades

Insider Trading History

Track insider trading activity for Kelly Michael Aaron. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Prime Medicine
Prime Medicine PRME
Director
Holding Value $243k 75,000 shares
Last Trade
Jun 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$230k 75,000 shares
$3.06
$3.24
Neogenomics
Neogenomics NEO
Director
Holding Value $769k 67,086 shares
Last Trade
Jun 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$241k 23,077 shares
$10.44
$11.47
Neogenomics
Neogenomics NEO
Director
Holding Value $183k 15,970 shares
Last Trade
Jun 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$282k 27,039 shares
$10.44
$11.47
Neogenomics
Neogenomics NEO
Director
Holding Value $0 0 shares
Last Trade
Jun 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$241k 23,077 shares
$10.44
$11.47
DMC Global
DMC Global BOOM
Director
Holding Value $436k 65,590 shares
Last Trade
May 13, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$125k 16,937 shares
$7.38
$6.65
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $0 0 shares
Last Trade
Apr 27, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$4.37M 301,815 shares
$14.49
$14.49
Prime Medicine
Prime Medicine PRME
Director
Holding Value $146k 45,000 shares
Last Trade
Aug 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$431k 106,578 shares
$4.04
$3.24
Prime Medicine
Prime Medicine PRME
Director
Holding Value $0 0 shares
Last Trade
Aug 01, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$431k 106,578 shares
$4.04
$3.24
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $1.08M 74,872 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$446k 74,872 shares
$5.96
$14.49
Prime Medicine
Prime Medicine PRME
Director
Holding Value $178k 55,000 shares
Last Trade
Jun 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$72.6k 55,000 shares
$1.32
$3.24
Neogenomics
Neogenomics NEO
Director
Holding Value $265k 23,077 shares
Last Trade
Jun 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$117k 16,107 shares
$7.28
$11.47
Neogenomics
Neogenomics NEO
Director
Holding Value $0 0 shares
Last Trade
Jun 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$89.2k 12,254 shares
$7.28
$11.47
Neogenomics
Neogenomics NEO
Director
Holding Value $505k 44,009 shares
Last Trade
Jun 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$89.2k 12,254 shares
$7.28
$11.47
Neogenomics
Neogenomics NEO
Director
Holding Value $57.4k 5,000 shares
Last Trade
May 27, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$38k 5,000 shares
$7.60
$11.47
DMC Global
DMC Global BOOM
Director
Holding Value $324k 48,653 shares
Last Trade
May 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$124k 17,580 shares
$7.04
$6.65
DMC Global
DMC Global BOOM
Director
Holding Value $207k 31,073 shares
Last Trade
Feb 26, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.9k 5,518 shares
$8.86
$6.65
Neogenomics
Neogenomics NEO
Director
Holding Value $0 0 shares
Last Trade
Aug 10, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$188k 11,336 shares
$16.55
$11.47
Neogenomics
Neogenomics NEO
Director
Holding Value $364k 31,755 shares
Last Trade
Aug 10, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$188k 11,336 shares
$16.55
$11.47
Prime Medicine
Prime Medicine PRME
Director
Holding Value $146k 45,000 shares
Last Trade
Jun 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$346k 45,000 shares
$7.68
$3.24
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $754k 52,054 shares
Last Trade
Jun 06, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$436k 42,467 shares
$10.27
$14.49

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up